关于非编码RNA调节网络和糖尿病脏病的向治疗的研究进展
Xiaxia Wang1, Ruge Jing1, Tong Yang1
1School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Frontiers in endocrinology
|August 13, 2025
概括
非编码RNA (ncRNA) 和它们的竞争性RNA (ceRNA) 网络是糖尿病病 (DN) 进展的关键调节者. 本综述探讨了ncRNA的作用,治疗潜力和DN治疗中的挑战.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 糖尿病病 (DN) 是糖尿病的一个主要并发症,导致严重的残疾和死亡率.
- 非编码RNAs (ncRNAs) 和竞争性RNA (ceRNA) 网络参与DN病变,影响细胞,如细胞和管状上皮细胞.
研究的目的:
- 系统地审查ncRNAs和ceRNA网络在DNA进展中的作用.
- 探索ncRNAs的治疗潜力,包括外体和干细胞衍生的ncRNAs,在DNA中.
- 讨论基于ncRNA的DNA诊断和治疗的挑战和未来方向.
主要方法:
- 文献综述侧重于ncRNAs,ceRNA网络和糖尿病病.
- 对外体的ncRNAs,干细胞衍生的ncRNAs和中国传统医学的DNA研究分析.
- 评估当前的治疗策略和与DNA中ncRNA相关的诊断挑战.
主要成果:
- ncRNA和ceRNA网络通过调节脏特异性细胞,在DNA中发挥多方面的作用.
- 外体ncRNA和干细胞衍生的ncRNA显示出对DN干预的希望.
- 传统中医成分可以准DNA中的ncRNA和ceRNA网络.
结论:
- ncRNAs代表了糖尿病病的有前途的生物标志物和治疗标.
- 需要进一步的研究来克服基于ncRNA的DN的诊断和治疗方面的挑战.
- 了解ncRNA机制为开发向DN治疗提供了新的途径.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
655
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
281
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
